LUNAR-factor VII

N/A

Report date: 2025/01/26 18:31:26

NME

Base Information

Drug NameLUNAR-factor VII

Drug Alias NamesiRNA therapy for factor VII-related disease(Arcturus)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionCoagulation factor VII modulators

TargetsCoagulation factor VII

Therapy Area/IndicationsFactor VII Deficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArcturus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsFactor VII Deficiency

Inactive IndicationsN/A

Other Information

ATC CodeN/A